期刊文献+

高葡萄糖培养增加H9C2成心肌细胞G蛋白偶联受体激酶2基因表达 被引量:1

High glucose up-regulates GRK2 gene expression in H9C2 cardiomyoblasts in vitro
下载PDF
导出
摘要 目的前期临床研究发现2型糖尿病患者淋巴细胞G蛋白偶联受体激酶2(GRK2)基因表达升高,为进一步探讨GRK2表达升高的分子机制,检测高糖对GRK2基因表达的影响。方法H9C2成心肌细胞随机分成5组分别加入以下培养液:空白对照组和不同葡萄糖梯度浓度组(0,5.5,12.5,25,33mmol/L),培养72h后采用RT-PCR,WESTERN BLOTTING分别测定GRK2-mRNA和磷酸化Akt(Ser473)蛋白含量比值。结果随着葡萄糖浓度升高,H9C2成心肌细胞的GRK2-mRNA表达水平呈剂量依赖性增加,pearson相关分析提示提示两者间存在直线相关(R=0.683,P<0.001),采用Student Newman-Keuls'q检验,各葡萄糖培养组与无糖培养比较均存在统计学差异(P=0.028,P=0.009,P<0.001)。而磷酸化Akt(Ser473)蛋白表达水平减少,各组间比较存在统计学意义(F=369.1,P<0.001),回归分析和pearson相关分析提示葡萄糖浓度与磷酸化AKt(Ser473)蛋白的表达呈线性负相关(R=-0.913,P<0.001)。结论高糖培养使GRK2表达升高,可能是参与心肌细胞葡萄糖利用受损的重要机制之一。 Objective To study the effect of high glucose on GRK2 gene expression in H9C2 cardiomyoblasts in vitro. Methods H9C2 cardiomyoblasts were cultured for 72 h in the presence of 0, 5.5, 12.5, 25 or 33 mmol/L glucose (with the osmotic pressure adjusted with monnitol). Semi-quantitative detection of GRK2 gene expression in H9C2 cardiomyoblasts was carried out using RT-PCR and phosph-Akt(Ser473) protein level was measured by Western blotting. Results Glucose in the culture medium (5.5 to 33 mmol/L) concentration-dependently increased the mRNA expression of GRK2 concentration and decreased phosphorylation Akt (ser473) level in in H9C2 cardiomyoblasts. Conclusion Increased GRK2 gene expression may play an important role in cardiac dysfunction in diabetes.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第3期472-474,共3页 Journal of Southern Medical University
基金 国家自然科学基金(30772142,30772620) 广东省医学科研基金(A2007005)
关键词 葡萄糖 成心肌细胞 G蛋白偶联受体激酶2 糖尿病 glucose cardiomyoblasts GRK2 diabetes
  • 相关文献

参考文献9

  • 1Anis Y, Leshem O, Reuveni H, et al. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes[J]. Diabetologia, 2004, 47(7): 1232-44.
  • 2Raake PW, Vinge LE, Gao E, et al. G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure[ J ]. Circ Res, 2008, 103: 413-22.
  • 3Iaccarino G, Barbato E, Cipolletta E, et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure[J]. Eur Heart J, 2005, 26(17): 1752-8.
  • 4Oyama N, Urasawa K, Kaneta S, et al. Chronic beta-adrenergic receptor stimulation enhances the expression of G-Protein coupled receptor kinases, GRK2 and GRK5, in both the heart and peripheral lymphocytes[J]. Circulation, 2005, 69 (8): 987-90.
  • 5陈红梅,林秋雄,谭虹虹,杨华章,余细勇.2型糖尿病患者外周血淋巴细胞G蛋白偶联受体激酶2基因表达升高[J].中国糖尿病杂志,2008,16(10):604-606. 被引量:1
  • 6Theilade J, Strom C, Christiansen T, et al. Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat [J]. Basic Res Cardiol, 2003, 98(2):97-103.
  • 7Usui I, Imamura T, Satoh H, et al. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation [ J ]. EMBO, 2004, 23(14): 2821-9.
  • 8Usui I, Imamura T, Babendure JL, et al. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes [J ]. Mol Endocrinol, 2005, 19(11): 2760-8.
  • 9Michele Ciccarelli, Giuseppe Rengo, Kurt Chuprun, et al. GRK2 inhibition prevents development of cardiac insulin resistance and impaired glucose uptake in post ischemic heart failure [J]. Circulation, 2008, 118: S-496S-7.

二级参考文献8

  • 1Iaccarino G,Barbato E,Cipolletta E,et al. Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart,2005,26 : 1752- 1758.
  • 2Yi XP, Zhou J ,Baker J ,et al. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure. Anat Rec A Discov Mol Cell Evol Biol,2005,282 :13-23.
  • 3Gros R,Ding Q, Chorazyczewski J, et al. The impact of blunted beta-adrenergic responsiveness on growth regulatory pathways in hypertension. Mol Pharmacol, 2006,69 : 317-327.
  • 4Oyama N,Urasawa K,Kaneta S,et al. Chronic beta-adrenergic receptor stimulation enhances the expression of G-Protein coupled receptor kinases,GRK2 and GRK5,in both the heart and peripheral lymphoeytes. Circulation, 2005,69 : 987-990.
  • 5Matsuda N, Hattori Y,Gando S, et al. Diabetes-induced down-regulation of betal adrenoceptor mRNA expression in rat heart. Biochem Pharmacol,1999,58:881- 885.
  • 6Anis Y, Leshem O, Reuveni H, et al. Antidiabetie effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia, 2004,47 : 1232-1244.
  • 7Usui I, Imamura T, Babendure JL, et al. G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor suhstrate-1 pathways in 3T3-L1 adipocytes. Mol Endocrinol, 2005,19 : 2760-2768.
  • 8Usui I, Imamura T, Satoh H, et al. GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO, 2004,23: 2821-2829.

同被引文献15

  • 1张玲,王洪新.异丙肾上腺素对大鼠心肌纤维化和相关细胞因子的影响[J].中国临床药理学与治疗学,2005,10(10):1186-1189. 被引量:3
  • 2Sellers Z M, Naren A P, Xiang Y, et al. MRP4 and CFTR in the regulation of cAMP and beta-adrenergic con- traction in cardiac myocytes[ J]. Eur J Pharmacol, 2012, 681 ( 1-3 ) :80-87.
  • 3Zhang X, Szeto C, Gao E, et al. Cardiotoxic and cardio- protective features of chronic beta-adrenergic signaling [J] Circ Res, 2013, 112 (3) :498-509.
  • 4Liu X, Ostrom R S, Insel P A. cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrot- ic phenotype in pulmonary fibroblasts [J ]. Am J Physiol Cell Physiol, 2004, 286 (5) : 1089-1099.
  • 5Sankar V, Pangayarselvi B, Prathapan A, et al. Desmo- dium gangeticum (Linn.) DC. exhibits antihypertrophic effect in isoproterenol-induced cardiomyoblasts via amel- ioration of oxidative stress and mitochondrial alterations [J]. J Cardiovasc Pharmacol, 2013, 61 ( 1 ) :23-34.
  • 6Rengo G, Lymperopoulos A, Zincarelli C, et al. Block- ade of beta-adrenoceptors restores the GRK2-mediated ad- renal alpha( 2 ) -adrenoceptor-catecholamine production ax- is in heart failure[J]. Br J Pharmacol, 2012, 166(8) : 2430-2440.
  • 7Monto F, Oliver E, Vicente D, et al. Different expres- sion of adrenoceptors and GRKs in the human myocardi- um depends on heart failure etiology and correlates to clinical variables[J]. Am J Physiol Heart Circ Physiol, 2012, 303 ( 3 ) : 368-376.
  • 8Liu S, Premont R T, Kontos C D, et al. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension[J]. Nat Med, 2005, 11(9):952-958.
  • 9Shimkunas R, Zhang Z, Wenk J F, et al. Left ventricu- lar myocardial contractility is depressed in the borderzone after posterolateral myocardial infarction [J]. Ann Tho- rac Surg, 2013, 95(5) :1619-1625.
  • 10Liu X, Sun S Q, Hassid A, et al. cAMP inhibits trans- forming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1/2 and Smad signaling in cardiac fibroblasts[J] Mol Phar-macol, 2006, 70 (6) : 1992-2003.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部